21 – 28 of 28
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- next »
- 2017
-
Mark
The number and affinity of productive IgE pairs determine allergen activation of mast cells
(
- Contribution to journal › Letter
-
Mark
Epithelial perviousness in allergic airways disease
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Major differences between human atopic dermatitis and murine models, as determined by using global transcriptomic profiling
(
- Contribution to journal › Article
-
Mark
Analysis of Safety and Tolerability Data in Pediatric Patients with Primary Immunodeficiency Diseases from Two Phase 2/3 Studies of Human Immune Globulin Subcutaneous, 20%
2017) 2017th AAAAI Annual Meeting In Journal of Allergy and Clinical Immunology 139(2, Supplement). p.217-217(
- Contribution to journal › Published meeting abstract
-
Mark
A New Subcutaneous Immunoglobulin 20% Formulation (SCIG 20%) with Individualized Infusion Parameters Resulted in a Positive Safety and Tolerability Profile in Patients with PIDD in Europe and North America
2017) 2017th AAAAI Annual Meeting In Journal of Allergy and Clinical Immunology 139(2, Supplement). p.216-216(
- Contribution to journal › Published meeting abstract
-
Mark
Best Possible Treatment for All Patients with Primary Immune Deficiency (PID) in Sweden Regardless of Social Factors, Sex, Age or Residence
2017) 2017th AAAAI Annual Meeting In Journal of Allergy and Clinical Immunology 139(2, Supplement). p.249-249(
- Contribution to journal › Published meeting abstract
-
Mark
Effectiveness of bronchial thermoplasty in patients with severe refractory asthma : Clinical and histopathologic correlations
(
- Contribution to journal › Article
- 2016
-
Mark
Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2 : A cohort study
(
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- next »